Clinical Trial Update: A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis

View source ↗

Summary

A completed clinical trial evaluating ibandronate (Boniva) and alendronate in postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Boniva (ibandronate)
• alendronate (alendronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Postmenopausal Osteoporosis | Status: COMPLETED